Delisting risk
GeoVax Labs
Clinical developer of an mpox/smallpox vaccine and gene-directed therapy for head-and-neck cancer.
$0.6400
After-hours close−0.08 (−11.22%)
At close$0.7209(+0.54%)
Something off on this page? Send us feedback.
Breakdown13F · Form 4
Institutions 4.52%333.4K sharesInsiders 0.04%2.9K sharesOther 95.44%7.03M shares
Shares outstanding 7.37M · Float 7.19M · 97.6% free float
A split settled inside the quarter being compared, so quarter-on-quarter change is not shown.
Institutions13F, as of Mar 31, 2026
15 holders · 333.4K shares
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Armistice Capital, LLC | 269.3K | 3.65% | May 15, 2026 | |
| Geode Capital Management, LLC | 36.1K | 0.49% | May 15, 2026 | |
| Virtu Financial LLC | 10.5K | 0.14% | May 14, 2026 | |
| Vanguard Fiduciary Trust Co | 5.1K | 0.07% | May 8, 2026 | |
| UBS Group AG | 4.2K | 0.06% | May 5, 2026 | |
| Tower Research Capital LLC (TRC) | 3.5K | 0.05% | May 15, 2026 | |
| Vanguard Capital Management LLC | 3.2K | 0.04% | May 15, 2026 | |
| BlackRock, Inc. | 1.1K | 0.01% | May 13, 2026 |
Beneficial owners13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Armistice Capital, LLC | 9.99% | 291.2K | 13G | May 15, 2026 ↗ |
| Mitchell P. Kopin | 9.99% | 233.3K | 13G | May 13, 2026 ↗ |
| Ayrton Capital LLC | 9.99% | 4.81M | 13G | Feb 11, 2026 ↗ |
| L1 Capital Global Opportunities Master Fund, Ltd. | 5.86% | 13G | Jul 7, 2025 ↗ | |
| Jane Street Group, LLC | 5.60% | 292.8K | 13G | Jun 9, 2026 ↗ |
InsidersForm 4
| Insider | Role | Shares | % outstanding | Filed |
|---|---|---|---|---|
| David A. Dodd | director, officer: President, CEO | 1.5K | 0.02% | Apr 1, 2025 |
| Mark Reynolds | officer: CFO | 561 | 0.01% | Mar 31, 2025 |
| John N. Jr Spencer | director | 456 | 0.01% | Apr 11, 2025 |
| John W. Sharkey | officer: VP, Business Development | 248 | 0.00% | Apr 10, 2025 |
| Kelly T. Jr. McKee | officer: Chief Medical Officer | 140 | 0.00% | Aug 8, 2025 |
1 ten-percent owner holds 0 shares by Form 4, outside the officers-and-directors figure above · 9 people have not refiled in the last 18 months (273 shares), so they are not in the figure above
Latest trades
No open-market trades in the last 12 months.
CongressHouse and Senate disclosures
Not reported.